USCAP The 2022 Classification of GU Tumors: Don’t Let the New Blue Book Make You Blue

The Classification, grading, staging and reporting of GU tumors have undergone significant changes in recent years due to molecular profiling. Histopathological classification plays a crucial role in predicting the prognosis and therapeutic response for cancer in precision medicine and targeted therapies. The fifth edition of the WHO Blue Book on Tumors of the Urinary System and Male Genital Organs is scheduled to be published in the spring of 2022, and it is a complete revision of the fourth edition published in 2016.

Expert faculty members have designed an educational program to guide attendees through the important changes and “new things” in the 5th edition of the WHO Blue Book to meet the patient management needs of contemporary times. The course aims to help practicing academic and community pathologists, and pathologists-in-training recognize, correctly diagnose, and classify new GU tumor types and apply new and modified grading and staging criteria for GU cancers.

This course also covers the new reporting requirements for GU tumors, and attendees will understand the role of histomorphological classification in precision patient management upon completion of the educational activity. This is an incredible opportunity to learn from some of the best minds in the field of GU pathology.

The course has structured comprehensive modules for Prostate Pathology, Kidney Pathology, Bladder Pathology, and Testicular Pathology. Each module will be taught by a renowned expert in the subject matter. Rajal Shah, MD will teach Prostate Pathology, Ming Zhou, MD, PhD will cover Kidney Pathology, Donna Hansel, MD, PhD will cover Bladder Pathology and Sunny Kao, MD will take the Testicular Pathology module.

The Prostate Pathology module, taught by Rajal Shah, MD, will enable pathologists to identify various types of prostate cancer, classify them based on new techniques and guidelines, and determine the proper clinical management of patients. Dr. Shah has been a professor of pathology at the University of California at San Francisco since 2010 and is a noted expert in the area of GU pathology.

In the Kidney Pathology module, attendees will learn the new changes in classification, grading, and staging of renal cancers with Ming Zhou, MD, PhD. Dr. Zhou is an Associate Professor of Pathology at the University of Texas Southwestern Medical Center and is highly regarded for his contributions to cancer research and education.

The Bladder Pathology module, taught by Donna Hansel, MD, PhD, will delve into the newly identified variants, subtypes, and genotypes of bladder cancer. Dr. Hansel is the Chair of the Department of Pathology at the University of California, San Diego, and is internationally recognized for her pioneering work in bladder cancer research.

The Testicular Pathology module, taught by Sunny Kao, MD, will cover the current issues, guidelines, and standard practices for the treatment of testicular tumors. Dr. Kao is a Professor of Pathology and Urology at the University of Alabama at Birmingham and has extensive experience and expertise in GU pathology.

This educational activity is comprehensive in its scope and will enable attendees to promptly recognize, classify, and communicate the proper diagnosis and management of GU cancers to patients, physicians, and healthcare providers. The course is designed to help pathologists develop their skills, broaden their knowledge base, and apply the latest advancements to their practices.

The course will be available for purchase in video format and comes with several benefits. Attendees can watch and re-watch the course content at their convenience, take notes, pause and rewind during the modules. Additionally, learners will have access to the course content for a limited time, expiring on November 15, 2025. This allows learners ample time to complete the course and earn CME credits.

In conclusion, the fifth edition of the WHO Blue Book on Tumors of the Urinary System and Male Genital Organs promises to be a game-changer in the field of GU pathology. It will provide a wealth of knowledge, insights, and guidelines concerning the classification, grading, staging, and reporting of GU tumors. The expert-led educational program is an excellent opportunity for pathologists to enhance their practice, and the video format offers a convenient way to learn. Professionals who want to update their existing knowledge should take advantage of this educational opportunity. Sign up and order the course today!

Product Details